BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
BillionToOne, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$101.03+2.91 (+2.97%)
Close on Oct 19, 2026
- Market cap
- $5.50B
- P/E (TTM)
- 721.6
- Dividend yield
- –
SEC filings
13 of BillionToOne's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2026 | Jun 16, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2026 | Apr 21, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 11, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2026 | Mar 4, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Dec 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2025 | Dec 9, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2025 | Nov 10, 2025 | SEC EDGAR |